Phibro Animal Health | PAHC - Gross Profit On Sales


Phibro Animal Health reported $133.5M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Align Technology USD 736.59M 53M Mar/2026
ANI Pharmaceuticals USD 124.18M 12.39M Dec/2025
Assertio Holdings USD 22.24M 970K Jun/2024
Aurora Cannabis CAD 46.62M 14.33M Dec/2025
Bristol-Myers Squibb USD 8.41B 381M Dec/2025
Canopy Growth CAD 21.47M 434K Dec/2025
Corcept Therapeutics USD 162.02M 37.56M Mar/2026
Eli Lilly USD 15.92B 1.33B Dec/2025
Henry Schein USD 1.07B 7M Mar/2026
Idexx Laboratories USD 722.74M 64.62M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Merck USD 10.85B 2.57B Dec/2025
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Pacira USD 126.64M 15.61M Mar/2026
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 157.37M 5.79M Dec/2025
Supernus Pharmaceuticals USD 129.36M 34.68M Mar/2026
Zoetis USD 1.62B 20M Mar/2026